Can you provide a comprehensive newborn case presentation proforma covering all relevant maternal, delivery, and neonatal details?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Comprehensive Newborn Case Presentation Proforma

A structured newborn case presentation should systematically cover maternal history, delivery details, immediate neonatal assessment, clinical status, and discharge planning to ensure complete documentation and optimal care coordination. 1, 2

I. Maternal History

A. Demographic Information

  • Age, parity, gravidity
  • Ethnicity, occupation, socioeconomic status
  • Marital status and family support structure 3

B. Prenatal Care and Risk Assessment

  • Gestational age determination (best estimate using early ultrasound dating - critical for periviable births) 4
  • Number and timing of prenatal visits
  • Antenatal screening results (blood type, Rh status, antibody screen, infectious disease screening including HIV, hepatitis B, syphilis, group B streptococcus)
  • Prenatal ultrasound findings (fetal growth, anatomy scan, placental location)
  • Genetic screening/testing results 5

C. Medical and Obstetric History

  • Chronic medical conditions (diabetes, hypertension, cardiac disease, thyroid disorders, psychiatric conditions including schizophrenia) 6, 5
  • Previous pregnancies and outcomes (preterm births, stillbirths, neonatal deaths, congenital anomalies)
  • Previous cesarean sections or uterine surgeries 3

D. Current Pregnancy Complications

  • Gestational hypertension, preeclampsia/eclampsia 6, 4
  • Gestational diabetes 6
  • Antepartum hemorrhage, placental abruption 6
  • Preterm premature rupture of membranes (PPROM) - timing and management 4, 7
  • Chorioamnionitis 8
  • Polyhydramnios/oligohydramnios
  • Intrauterine growth restriction 6
  • Multiple gestation 6

E. Medications and Exposures

  • Current medications (including psychotropic medications, antihypertensives, insulin)
  • Antenatal corticosteroids - timing and number of doses 4, 7
  • Magnesium sulfate for neuroprotection (if <32 weeks) 4
  • Antibiotics for PPROM or GBS prophylaxis 4, 7
  • Substance use (tobacco, alcohol, illicit drugs)
  • Teratogenic exposures 9

II. Labor and Delivery Details

A. Labor Characteristics

  • Spontaneous versus induced labor - indication if induced 4, 7
  • Duration of labor stages
  • Use of partograph 7
  • Fetal distress - specific findings (heart rate patterns, meconium-stained fluid) 6, 8
  • Prolonged rupture of membranes - exact duration 6, 8

B. Delivery Information

  • Mode of delivery (spontaneous vaginal, instrumental, cesarean section) 6, 10
    • If cesarean: indication (elective vs. urgent/emergent), type of incision
    • If instrumental: type (forceps vs. vacuum), indication
  • Gestational age at delivery (weeks + days) 4, 10
  • Presentation (vertex, breech, transverse)
  • Anesthesia type (epidural, spinal, general)
  • Complications (shoulder dystocia, cord prolapse, uterine rupture)

C. Immediate Delivery Room Events

  • Umbilical cord management - timing of clamping (delayed ≥60 seconds vs. early) 1, 10
  • Cord milking performed (yes/no)
  • Meconium-stained amniotic fluid - consistency (thin vs. thick) 8, 7
  • Nuchal cord - number of loops, tight vs. loose
  • Placental abnormalities (abruption, previa, accreta)

III. Immediate Neonatal Assessment

A. Birth Parameters

  • Birth weight (grams) - classify as appropriate/small/large for gestational age 6, 10
  • Length (centimeters)
  • Head circumference (centimeters)
  • Sex 4

B. Initial Vital Signs and Apgar Scores

  • Apgar scores at 1 and 5 minutes (extend to 10,15,20 minutes if resuscitation ongoing) 1, 10
  • Initial heart rate, respiratory rate, temperature
  • Time to first breath/cry 11

C. Resuscitation Requirements 1

  • Initial steps performed (drying, stimulation, airway positioning/suctioning)
  • Positive pressure ventilation - timing initiated, duration, response
  • Supplemental oxygen - initial FiO2, adjustments based on oxygen saturation targets
  • Endotracheal intubation - indication, timing, tube size 8
  • Chest compressions - indication, duration 8
  • Medications administered (epinephrine, volume expanders - type and dose) 8
  • Duration of resuscitation (note if >10 minutes) 8
  • Personnel present (neonatologist, pediatrician, anesthesiologist, respiratory therapist)

D. Physical Examination at Birth

General Appearance

  • Skin color (pink, cyanotic, pale, plethoric, jaundiced)
  • Skin integrity (vernix, lanugo, peeling, rashes, birthmarks)
  • Dysmorphic features (facial anomalies, limb abnormalities) 9, 12
  • Obvious congenital anomalies 9, 13, 12

Head and Neck

  • Head shape (molding, caput succedaneum, cephalohematoma)
  • Fontanelles (size, tension)
  • Eyes (red reflex, conjunctival hemorrhage, discharge) 9
  • Ears (position, shape, patency of canals) 9
  • Nose (patency of nares)
  • Oral cavity (cleft lip/palate, tongue tie, natal teeth) 12
  • Neck (masses, clavicular fractures)

Chest and Respiratory

  • Respiratory effort (rate, retractions, grunting, flaring) 1
  • Breath sounds (equal, adventitious sounds)
  • Chest wall abnormalities

Cardiovascular

  • Heart rate and rhythm
  • Heart sounds (murmurs - timing, location, intensity)
  • Pulses (brachial and femoral - quality and symmetry)
  • Perfusion (capillary refill time, color)

Abdomen

  • Shape (scaphoid, distended)
  • Umbilical cord (number of vessels - should be 2 arteries, 1 vein) 14
  • Abdominal wall defects (gastroschisis, omphalocele) 13
  • Organomegaly
  • Masses

Genitourinary

  • Sex assignment (ambiguous genitalia if present)
  • Males: descended testes, hypospadias, meatal position
  • Females: labial fusion, vaginal patency
  • Anus (patency, position)

Musculoskeletal

  • Tone (hypotonic, hypertonic, appropriate) 1
  • Activity level 1
  • Hip examination (Barlow and Ortolani maneuvers)
  • Spine (sacral dimple, hair tuft, masses)
  • Extremities (digits count, syndactyly, polydactyly, clubfoot, positional deformities) 15, 12

Neurological

  • Level of alertness 1
  • Primitive reflexes (Moro, grasp, rooting, suck)
  • Cry (quality, pitch)
  • Seizure activity

IV. Transitional Care and Initial Management

A. Temperature Management 1, 11

  • Admission temperature (target 36.5-37.5°C)
  • Method of warming (radiant warmer, incubator, skin-to-skin contact)
  • Special considerations for preterm infants (plastic wrap, thermal mattress) 9, 1

B. Respiratory Support

  • Room air vs. supplemental oxygen
  • Continuous positive airway pressure (CPAP) 10
  • Mechanical ventilation - settings if applicable 10
  • Surfactant administration - timing and response 10

C. Cardiovascular Support

  • Intravenous access (peripheral, umbilical venous/arterial catheter) 9
  • Fluid management
  • Inotropic support if required

D. Metabolic Management

  • Blood glucose monitoring - initial value and frequency 2
  • Intravenous dextrose if indicated
  • Electrolyte monitoring (calcium, sodium, potassium) 10

E. Infection Risk Assessment 9, 8

  • Risk factors present (maternal fever, chorioamnionitis, prolonged rupture of membranes >18 hours, inadequate GBS prophylaxis)
  • Sepsis evaluation performed (blood culture, complete blood count, C-reactive protein)
  • Antibiotic therapy - indication, agents, duration

F. Prophylactic Interventions 14

  • Vitamin K administration - dose (1 mg IM), timing
  • Erythromycin eye prophylaxis - timing 9
  • Hepatitis B vaccine - if indicated, timing 14
  • Hepatitis B immunoglobulin - if maternal HBsAg positive

V. Ongoing Neonatal Assessment

A. Feeding Plan 11, 2, 14

  • Feeding method (breastfeeding, bottle, gavage tube)
  • Breast milk vs. formula - type if formula
  • Feeding tolerance (volume, frequency, residuals, emesis)
  • Weight trend (daily weights, percentage loss from birth weight)
  • Lactation support provided 11

B. Jaundice Assessment 10

  • Visual assessment timing
  • Transcutaneous or serum bilirubin levels - timing and values
  • Phototherapy - indication, duration, response
  • Risk factors (ABO/Rh incompatibility, G6PD deficiency, cephalohematoma)

C. Hematologic Status 2

  • Hematocrit/hemoglobin - timing of assessment
  • Blood type and Coombs test if indicated
  • Platelet count if clinically indicated 12

D. Screening Tests 2, 14

  • Newborn metabolic screening - timing of collection (ideally 24-48 hours of age)
  • Hearing screening - method (OAE vs. ABR), results 2
  • Congenital heart disease screening (pulse oximetry) - timing, results
  • Critical congenital heart disease - if murmur or abnormal screening

E. Ophthalmologic Assessment 2

  • Retinopathy of prematurity screening - if <32 weeks or <1500g, timing of first exam
  • Red reflex examination

F. Neurodevelopmental Assessment 2

  • Neurological examination findings
  • Neurobehavioral status demonstrated to parents 2
  • Hypoxic-ischemic encephalopathy assessment if birth asphyxia 10
  • Therapeutic hypothermia if indicated

VI. Special Considerations for High-Risk Infants

A. Prematurity-Related Issues 9, 4, 16

  • Gestational age-specific risks (respiratory distress syndrome, apnea, feeding intolerance, temperature instability, hypoglycemia, jaundice, infection, intraventricular hemorrhage, patent ductus arteriosus) 10, 13
  • Level of care required (Level I, II, IIIA, IIIB, IIIC) 16
  • Cranial ultrasound - timing and findings if performed

B. Congenital Anomalies 9, 13, 12

  • Specific anomaly description
  • Genetic evaluation - karyotype, microarray, specific gene testing
  • Surgical consultation and planning
  • Associated anomalies screening

C. Maternal Conditions Affecting Neonate 6

  • Maternal diabetes - neonatal hypoglycemia, polycythemia, hypocalcemia
  • Maternal hypertension/preeclampsia - growth restriction, thrombocytopenia
  • Maternal psychiatric illness (schizophrenia) - increased risk of complications 6

D. Technology Dependence 2

  • Oxygen requirement
  • Feeding tube (nasogastric, gastrostomy)
  • Tracheostomy
  • Home monitoring equipment

VII. Discharge Planning 2, 14

A. Clinical Readiness Criteria 2

  • Stable vital signs in open crib maintaining temperature
  • Adequate feeding (breast or bottle) with consistent weight gain
  • No apnea/bradycardia for specified period (typically 5-7 days)
  • Jaundice resolved or stable without phototherapy
  • Medications finalized - parents demonstrate administration competency
  • Car seat tolerance test completed (especially preterm infants) 2
  • Circumcision healed if performed

B. Screening and Assessments Completed 2

  • Newborn metabolic screening results reviewed
  • Hearing screening passed or follow-up arranged
  • Ophthalmology examination completed if indicated
  • Unresolved medical problems identified with follow-up plans 2

C. Family Preparedness 2

  • At least 2 caregivers identified and trained 2
  • Infant CPR training completed 2
  • Demonstration of care competencies:
    • Feeding technique
    • Medication administration
    • Temperature measurement
    • Recognition of illness signs 2
    • Safe sleep positioning 11, 2
    • Proper car seat use 2
    • Equipment operation if technology-dependent 2

D. Home Environment Assessment 2

  • 24-hour telephone access
  • Adequate heating, electricity, safe water supply
  • Emergency plan (loss of utilities, natural disaster) 2
  • Emergency medical services notified if technology-dependent 2

E. Follow-up Care Arranged 2

  • Primary care physician identified and accepts care 2
  • First appointment scheduled (typically 2-3 days post-discharge, earlier for high-risk)
  • Subspecialty referrals made (cardiology, surgery, neurology, etc.) 2
  • Neurodevelopmental follow-up arranged if indicated 2
  • Home nursing visits scheduled if complex care needs 2
  • Lactation support arranged if breastfeeding

F. Discharge Documentation

  • Complete hospital course summary 2
  • Discharge weight, length, head circumference
  • Discharge medications - name, dose, frequency, indication
  • Immunizations given
  • Pending test results - plan for communication
  • Warning signs requiring immediate medical attention
  • Written care instructions in family's preferred language

VIII. Special Populations

A. Periviable Births (22-25 weeks) 4

  • Multidisciplinary counseling provided (obstetrics, neonatology) 4
  • Resuscitation plan discussed and documented 4
  • Gestational age-specific interventions (antenatal steroids, tocolysis, magnesium sulfate, cesarean for fetal indication) 4

B. Collodion Baby/Harlequin Ichthyosis 9

  • NICU admission required 9
  • Multidisciplinary team (dermatology, ophthalmology, ENT, plastic surgery) 9
  • Intensive emollient therapy (3-8 times daily) 9
  • Infection monitoring (bacterial swabs twice weekly) 9
  • Nutritional support via gavage if needed 9

C. COVID-19 Exposed Neonates 10

  • Cord clamping timing - delayed ≥60 seconds recommended 10
  • Neonatal testing protocol
  • Isolation precautions
  • Breastfeeding support with appropriate precautions

This proforma ensures comprehensive documentation of all maternal, delivery, and neonatal factors critical for optimal newborn care, risk stratification, and discharge planning. 1, 2 The systematic approach facilitates communication among multidisciplinary teams and ensures no critical element is overlooked in the care of healthy or high-risk newborns.

References

Guideline

periviable birth: interim update.

American Journal of Obstetrics and Gynecology, 2016

Research

[Recommendations for the care of healthy newborn infants].

Anales espanoles de pediatria, 2001

Research

The Newborn Examination and Pediatric Foot Development.

Clinics in podiatric medicine and surgery, 2027

Guideline

levels of neonatal care.

Pediatrics, 2012

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.